RI
RTW Investments Portfolio holdings
AUM
$7.02B
This Quarter Return
+9.11%
1 Year Return
+28.16%
3 Year Return
+245.48%
5 Year Return
+425.65%
10 Year Return
+5,642.23%
AUM
$7.02B
AUM Growth
+$7.02B
(+7.4%)
Cap. Flow
+$119M
Cap. Flow
% of AUM
1.69%
Top 10 Holdings %
Top 10 Hldgs %
49.95%
Holding
78
New
10
Increased
26
Reduced
8
Closed
5
Top Buys
| 1 |
Neurocrine Biosciences
NBIX
|
$133M |
| 2 |
Zai Lab
ZLAB
|
$83.9M |
| 3 |
Quest Diagnostics
DGX
|
$72M |
| 4 |
Abbott
ABT
|
$60.4M |
| 5 |
Guardant Health
GH
|
$44.6M |
Top Sells
| 1 |
Axsome Therapeutics
AXSM
|
$147M |
| 2 |
Akero Therapeutics
AKRO
|
$104M |
| 3 |
Globus Medical
GMED
|
$82.4M |
| 4 |
RAPT Therapeutics
RAPT
|
$82.3M |
| 5 |
Alkermes
ALKS
|
$63M |
Sector Composition
| 1 | Healthcare | 99.89% |
| 2 | Financials | 0.11% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
76
Glaukos
GKOS
$5.5B
| – | – |
-190,000
| Closed | -$18.7M |
|
|
77
Globus Medical
GMED
$8.27B
| – | – |
-1,125,000
| Closed | -$82.4M |
|
|
BIOA
78
BioAge Labs, Inc. Common Stock
BIOA
$167M
| – | – |
-786,353
| Closed | -$2.96M |
|